ISMP
ISMP
Home Support ISMP Newsletters Webinars Report Errors Educational Store Consulting FAQ Tools About Us Contact Us
ISMP
ISMP
ISMP Facebook

Textbook and Publication Errata

 

Errors reported in publications

A recent issue of Pharmacotherapy1 contains an error regarding the duration of vincristine dosing as a part of a CAV regimen. The article, referenced below, listed the vincristine dose as 1.4 mg/m2 to be given on days 1-5 of the chemotherapy regimen.

In fact, vincristine should only be given on day 1 of the regimen. The publisher is aware of this error, and plans to print a correction on page 1144 of the September 2000 issue (20:9).

1. Adams V. Adverse events associated with chemotherapy for common cancers. Pharmacotherapy 2000;20(7):96-103S.

 

 

Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
Med-ERRS Med-ERRS | MSOMedication Safety Officers Society | Consumer Medication SafetyFor consumers
 ISMP Canada ISMP Canada | ISMP Spain ISMP Spain | ISMP Brasil ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2017 Institute for Safe Medication Practices. All rights reserved

 
ISMP
ISMP